The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...
Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...
Medical Device Network on MSN
FDA expands use of Organon’s contraception implant up to 5 years
Organon’s Nexplanon can now be implanted for up to five years after the FDA approved a supplemental New Drug Application by ...
The birth control implant, brand name Nexplanon, is considered one of the most effective reversible contraceptive methods available. It provides protection from pregnancy for up to three years with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback